ImmunoPrecise Antibodies Ltd. submitted a Form 6-K report to the SEC on June 27, 2024, indicating it will file annual reports under Form 20-F. This is significant information for investors regarding the company's compliance and reporting practices.
AI Assistant
IMMUNOPRECISE ANTIBODIES LTD
2024
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.